Related Experiment Video
Updated: Mar 16, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.2K
[Radiotherapy of lymphomas]
I Barillot1, M A Mahé2, D Antoni3
1Société française de radiothérapie oncologique, centre Antoine-Béclère, 45, rue des Saints-Pères, 75005 Paris, France; Pôle régional de cancérologie HS-Kaplan, CHRU de Tours, 2, boulevard Tonnellé, 37000 Tours, France; Université François-Rabelais, 37000 Tours, France.
Summary
Radiotherapy remains key for early-stage Hodgkin
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Radiotherapy is a cornerstone in treating early-stage Hodgkin's lymphoma.
- Its application in non-Hodgkin's lymphomas is more restricted but utilizes similar principles.
Purpose of the Study:
- To present French recommendations for radiotherapy in lymphoma treatment.
- To detail preparation and irradiation technique choices.
Main Methods:
- Review of current French guidelines and practices.
- Analysis of radiotherapy principles applicable to various lymphoma types.
Main Results:
- Hodgkin's lymphoma treatment heavily relies on radiotherapy.
- Radiotherapy techniques for non-Hodgkin's lymphomas are based on established principles.
Conclusions:
- French recommendations emphasize specific preparation and technique selection for lymphoma radiotherapy.
- Standardized principles guide radiotherapy application across different lymphoma histological types.
Related Concept Videos
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

